These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5783591)

  • 1. Irreversible enzyme inhibitors. CXLVI. Active-site-directed irreversible inhibitors of xanthine oxidase derived from 9-(acylamidophenyl)guanines substituted with a terminal sulfonyl fluoride.
    Baker BR; Wood WF
    J Med Chem; 1969 Mar; 12(2):211-4. PubMed ID: 5783591
    [No Abstract]   [Full Text] [Related]  

  • 2. Irreversible enzyme inhibitors. CXLVII. Candidate active-site-directed irreversible inhibitors of xanthine oxidase derived from 9-(p-acylamidoalkoxyphenyl)guanines bearing a terminal sulfonyl fluoride.
    Baker BR; Wood WF
    J Med Chem; 1969 Mar; 12(2):214-6. PubMed ID: 5783592
    [No Abstract]   [Full Text] [Related]  

  • 3. Irreversible enzyme inhibitors. CXXV. Active-site-directed irreversible inhibitors of xanthine oxidase derived from arylpurines and pyrazolo[3,4-d]pyrimidines bearing a terminal sulfonyl fluoride.
    Baker BR; Kozma JA
    J Med Chem; 1968 Jul; 11(4):656-61. PubMed ID: 5671223
    [No Abstract]   [Full Text] [Related]  

  • 4. Irreversible enzyme inhibitors. 148. Active-site-directed irreversible inhibitors of guanine deaminase derived from 9-phenylguanine bearing a terminal sulfonyl fluoride.
    Baker BR; Wood WF
    J Med Chem; 1969 Mar; 12(2):216-20. PubMed ID: 5783593
    [No Abstract]   [Full Text] [Related]  

  • 5. Irreversible enzyme inhibitors. 103. 9-(p-Bromoacetamidophenyl)guanine, an irreversible inhibitor of xanthine oxidase.
    Baker BR; Wood WF
    J Med Chem; 1967 Nov; 10(6):1106-9. PubMed ID: 6056038
    [No Abstract]   [Full Text] [Related]  

  • 6. Irreversible enzyme inhibitors. CII. On the mode of phenyl binding of 9-phenylguanine to guanine deaminase and xanthine oxidase.
    Baker BR; Wood WF
    J Med Chem; 1967 Nov; 10(6):1101-5. PubMed ID: 6056037
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and properties of the sulfonyl analogues of 4(5)-aminoimidazole-5(4)-carboxamide, 4(5)-(formylamino)imidazole-5(4)-carboxamide, guanine, and xanthine.
    Huang BS; Chello PL; Yip L; Parham JC
    J Med Chem; 1980 May; 23(5):575-7. PubMed ID: 6892931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible enzyme inhibitors. CXLV. Proteolytic enzymes. 8. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from alpha-(2-carboxy-4-chlorophenoxy)acetamide bearing a terminal sulfonyl fluoride.
    Baker BR; Hurlbut JA
    J Med Chem; 1969 Jan; 12(1):118-22. PubMed ID: 5763006
    [No Abstract]   [Full Text] [Related]  

  • 9. Irreversible enzyme inhibitors. CXV. Proteolytic enzymes. V. Active-site-directed irreversible inhibitors of trypsin derived from p-(phenoxyalkoxy) benzamidines with a terminal sulfonyl fluoride.
    Baker BR; Erickson EH
    J Med Chem; 1968 Mar; 11(2):245-9. PubMed ID: 5654210
    [No Abstract]   [Full Text] [Related]  

  • 10. Irreversible enzyme inhibitors. CXLIV. Proteolytic enzymes. VII. Additonal active-site-directed irreversible inhibitors of trypsin derived from m- and p-(phenoxyalkoxy)benzamidines with a terminal sulfonyl fluoride.
    Baker BR; Erickson EH
    J Med Chem; 1969 Jan; 12(1):112-7. PubMed ID: 5763005
    [No Abstract]   [Full Text] [Related]  

  • 11. Irreversible enzyme inhibitors. CXIV. Proteolytic enzymes. IV. Additional active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides bearing a terminal sulfonyl fluoride.
    Baker BR; Hurlbut JA
    J Med Chem; 1968 Mar; 11(2):241-5. PubMed ID: 5654209
    [No Abstract]   [Full Text] [Related]  

  • 12. Irreversible enzyme inhibitors. 138. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenethyl)-- 2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine with a terminal sulfonyl fluoride.
    Baker BR; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):89-91. PubMed ID: 5763048
    [No Abstract]   [Full Text] [Related]  

  • 13. Irreversible enzyme inhibitors. 185. Active-site-directed irreversible inhibitors of guanine deaminase derived from 9-phenylguanine bearing a terminal sulfonyl fluoride. 2.
    Baker BR; Siebenneick HU
    J Med Chem; 1971 Sep; 14(9):802-5. PubMed ID: 5168672
    [No Abstract]   [Full Text] [Related]  

  • 14. Irreversible enzyme inhibitors. 143. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenoxypropyl)-2,4-diamino-6-methylpyrimidine with a terminal sulfonyl fluoride.
    Baker BR; Meyer RB
    J Med Chem; 1969 Jan; 12(1):108-11. PubMed ID: 5763004
    [No Abstract]   [Full Text] [Related]  

  • 15. Irreversible enzyme inhibitors. CXLII. Further studies on active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-Aminophenoxypropyl)-2,4,6-triaminopyrimidine bearing a terminal sulfonyl fluoride.
    Baker BR; Meyer RB
    J Med Chem; 1969 Jan; 12(1):104-7. PubMed ID: 5763003
    [No Abstract]   [Full Text] [Related]  

  • 16. Irreversible enzyme inhibitors. CXXXVII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenoxymethyl)-2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine bearing a terminal sulfonyl fluoride.
    Baker BR; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):86-8. PubMed ID: 5763047
    [No Abstract]   [Full Text] [Related]  

  • 17. Irreversible enzyme inhibitors. CXXVI. Hydrocarbon interaction with xanthine oxidase by phenyl substituents on purines and pyrazolo[3,4-d]pyrimidines.
    Baker BR; Wood WF; Kozma JA
    J Med Chem; 1968 Jul; 11(4):661-6. PubMed ID: 5671224
    [No Abstract]   [Full Text] [Related]  

  • 18. 2-pyridylimidazoles as inhibitors of xanthine oxidase.
    Baldwin JJ; Lumma PK; Novello FC; Ponticello GS; Sprague JM; Duggan DE
    J Med Chem; 1977 Sep; 20(9):1189-93. PubMed ID: 926119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible enzyme inhibitors. 178. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 1-(4-benzyloxy-3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with a terminal sulfonyl fluoride.
    Baker BR; Ashton WT
    J Med Chem; 1970 Nov; 13(6):1161-5. PubMed ID: 5479857
    [No Abstract]   [Full Text] [Related]  

  • 20. Irreversible enzyme inhibitors. CLXXIX. Active-site-directed irreversible enzyme inhibitors of dihydrofolate reductase from 1-(3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with oxyamide bridges to a terminal sulfonyl fluoride.
    Baker BR; Ashton WT
    J Med Chem; 1970 Nov; 13(6):1165-70. PubMed ID: 5479858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.